Drug Shortage Report for BYSTOLIC
| Report ID | 153204 |
| Drug Identification Number | 02399024 |
| Brand name | BYSTOLIC |
| Common or Proper name | BYSTOLIC (Nebivolol) TABLETS |
| Company Name | ABBVIE CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | NEBIVOLOL |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30s |
| ATC code | C07AB |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-01-20 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2022-08-31 |
| Shortage status | Resolved |
| Updated date | 2022-09-01 |
| Company comments | Bystolic 20mg 90s available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
| Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-09-01 | English | Compare |
| v6 | 2022-08-31 | French | Compare |
| v5 | 2022-08-31 | English | Compare |
| v4 | 2022-01-21 | English | Compare |
| v3 | 2022-01-20 | French | Compare |
| v2 | 2022-01-20 | English | Compare |
| v1 | 2022-01-20 | English | Compare |
Showing 1 to 7 of 7